#midcaps

This text was written by Comply with The Barnacle is a quantitative analyst and has been out and in of the investing enterprise since 2003. He’s a former member of Marketocracy’s M100 Membership. He has a level in arithmetic and believes that arithmetic is the foundation of all success. If the numbers inform one to do one thing, then do it. When one reads his posts, one will notice that.…

“I think we have to dig a little bit deeper not just into this one company, but in the approach with which we are investing in different companies. So when we want to buy companies, we want to buy companies which are having better than their peer group average returns on equity and better than their peer group average growth over the next four to five year period,” says Vinay Paharia, CIO, PGIM…

Vijaya Diagnostics IPO issue subscribed 4.5x, Ami Organics sees 64x demand

Mumbai: The preliminary public choices (IPOs) of of Vijaya Diagnostics Centre and Ami Organics closed with a subscription of 4.5 instances and 64.6 instances, respectively, on Friday. Analysts mentioned revival within the mid and smallcaps within the secondary market after a weak efficiency in August has helped these IPOs, although the market individuals favoured specialty chemical compounds…

Should you be worried about valuation of smallcaps?

Players with strong balance sheets and strong brands in the midcap and smallcap space are gaining market share from unorganised players, says Aishvarya Dadheech, Ambit Asset Management in this interview. Edited excerpts: Let us start by understanding your thoughts on smallcaps. Do you find froth in valuations?Midcaps and smallcaps outperformed largecaps in calendar year 2020. We are seeing…